RÉSUMÉ
BACKGROUND: The contribution of genetic factors such as the presence of ApoE allele e4 and its association with psychological consequences post stroke remains unknown within Middle-Eastern regions. This study examined the association of ApoE genotype with cognitive impairment and mood in stroke patients and compare with healthy older adults in Bahrain. METHOD: A prospective sample of n = 62 stroke patients (case group) and n = 53 healthy ageing individuals (control group) were eligible to participate in the study. A neuropsychological battery of cognitive assessments were conducted on all participants, and then stratified by cognitive function: no cognitive impairment, mild cognitive impairment and moderate to severe cognitive impairment. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS). RESULTS: Most frequent ApoE genotype was e2/e3 in case (44%) and control groups (63%). ApoE allele e3 had the highest frequency for both groups with all stroke patients presenting with this allele and 86% for the control group (χ2 = 12.14, p < .0001). Stroke patients' non-carriers for ApoE allele e4 performed better on all cognitive measures but differences were not statistically significant (ns). Carriers of ApoE allele e2 in both groups had less mood symptoms compared to non-carriers. DISCUSSION: ApoE genotype e3/e4 and e4/e4 was low in this Bahraini cohort explaining why there may been no significant associations found for this genotype variant with cognitive impairment. Further investigation of cognitive impairment and mood dysregulation with the different variants of the ApoE gene in general ageing and stroke populations is required from different ethno-cultural groups and geographical regions globally.
Sujet(s)
Apolipoprotéines E/génétique , Dysfonctionnement cognitif/complications , Accident vasculaire cérébral/complications , Bahreïn , Études cas-témoins , Dysfonctionnement cognitif/génétique , Études de cohortes , Humains , Adulte d'âge moyen , Tests neuropsychologiques , Études prospectives , Facteurs de risque , Accident vasculaire cérébral/génétiqueRÉSUMÉ
INTRODUCTION: The link between metacognition and mood has been well established, particularly in other conditions with psychological comorbidity, however, there is no evidence regarding this association in the area of stroke. AIM: The aim of this study was to examine the association between metacognition, based on the Self-Regulatory Executive Function model, and mood symptoms in the acute phase after stroke. METHODS: One hundred thirty patients were recruited to a prospective stroke study in Bahrain, and n = 64 were assessed for mood and cognition. A neuropsychological battery of cognitive assessments included the following measures: the Mini-Mental State Examination, the Trail Making Test (A+B), and the Metacognition Questionnaire 30 (MCQ-30) for metacognition. The Hospital Anxiety and Depression Scale assessed mood symptoms, and stroke severity was measured using the National Institute of Health Stroke Severity Scale. RESULTS: Total MCQ-30 scores were significantly associated with both anxiety (r = .47, P = .001) and depression (r = .54, P <. 0001). The MCQ-30 subscales' cognitive confidence, cognitive self-consciousness, and uncontrollability/danger were the specific factors to be associated with mood symptoms (P < .01). Global cognition (r =.32, P < .01), but not executive function, was significantly associated with depression only. Metacognition remained a statistically significant correlate with depression (ß = .42, P < .0001) and anxiety (ß = .51, P < .0001) after adjusting for education and global cognition. DISCUSSION: Metacognition is a better determinant of mood symptoms after stroke, especially in regions where illiteracy levels are high in older populations, in comparison to executive function and global cognition.
Sujet(s)
Affect , Anxiété/psychologie , Dépression/psychologie , Fonction exécutive/physiologie , Métacognition/physiologie , Accident vasculaire cérébral/psychologie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Anxiété/diagnostic , Anxiété/étiologie , Bahreïn , Cognition , Dépression/diagnostic , Dépression/étiologie , Humains , Adulte d'âge moyen , Tests neuropsychologiques , Études prospectives , Accident vasculaire cérébral/complications , Accident vasculaire cérébral/physiopathologie , Réadaptation après un accident vasculaire cérébral , Enquêtes et questionnaires , Trail making testRÉSUMÉ
Mandatory newborn screening for metabolic disorders has not been implemented in most Middle Eastern countries. Early detection and treatment of inborn errors of metabolism can reduce mortality and minimize morbidity. Preliminary studies conducted in some parts of Middle East suggest that the incidences of inborn errors of metabolism are reported to be higher in the region than anywhere else in the world due to the consanguinity. In this study the incidence of inborn errors of amino acids, organic acids and fatty acids oxidation disorders was investigated from the results of blood spot analysis of 1986 symptomatic children from 1st January 2008 to 31st of December 2011. Out of 1986 newborns screened 25 infants were diagnosed and confirmed with amino acids (n=11), organic acids (n=9) and fatty acids oxidation (n=5) disorders. Overall incidences based on number of live birth between 2008 and 2011 inclusive were 1:6000, 1:8000 and 1:14,000 for amino acids, organic acids and fatty acids oxidation disorders; respectively. Out of 25 infants diagnosed, 21 were the children of first cousin marriages. Results from this study suggest high incidence of inborn errors of amino acids, organic acids and fatty acids oxidation metabolism in Bahrain and significant contribution of consanguinity in inherited metabolic disorders. Mandatory screening for inborn errors of metabolism in Bahrain is highly recommended.
Sujet(s)
Aminoacidopathies congénitales/diagnostic , Nouveau-né , Erreurs innées du métabolisme lipidique/diagnostic , Dépistage néonatal , Aminoacidopathies congénitales/génétique , Acides aminés/génétique , Acides aminés/métabolisme , Bahreïn , Diagnostic précoce , Acides gras/génétique , Acides gras/métabolisme , Femelle , Humains , Erreurs innées du métabolisme lipidique/génétique , Mâle , Spectrométrie de masse ESI , Spectrométrie de masse en tandemRÉSUMÉ
Brucellosis was studied in 2,225 camels, 20 camel nomads and 33 abattoir workers in certain nomadic localities in Sudan, using serum and milk samples. Lymph nodes, testicular tissues and udder tissues from positive camels and hygroma aspirates from three affected cows were used for isolation of Brucella. Serum samples were examined by Rose Bengal plate test (RBPT), modified RBPT (mRBPT), serum agglutination test (SAT) and competitive enzyme-linked immunosorbent assay (cELISA), and milk by the milk ring test. Overall seroprevalence in camels (milk and serum samples) was 37.5%. The seroprevalence in males was 28.2% and in females 40.1%. Twelve (60%) of the 20 nomads and three (9%) of the 33 abattoir workers had positive antibody titres. Brucella abortus biovar 6 was isolated from two camels and three cows. Two isolates, one from each species, were atypical. The bacteriological findings suggested that camels were infected from cattle, the primary hosts of B. abortus. The mRBPT was suitable for screening camel sera for brucellosis, but the cELISA detected 2.1% more positives. The SAT antibody concentrations ranged between < 13 and 3,282 IU/ml.
Sujet(s)
Maladies des agriculteurs/diagnostic , Brucellose/diagnostic , Brucellose/épidémiologie , Chameaux , Tests sérologiques/normes , Abattoirs , Maladies des agriculteurs/épidémiologie , Animaux , Anticorps antibactériens/sang , Brucella/immunologie , Brucella/isolement et purification , Brucellose bovine/diagnostic , Brucellose bovine/épidémiologie , Bovins , Femelle , Cochons d'Inde , Humains , Noeuds lymphatiques/microbiologie , Mâle , Glandes mammaires animales/microbiologie , Mésentère , Lait/microbiologie , Études séroépidémiologiques , Soudan/épidémiologie , Testicule/microbiologie , Population de passage et migrantsRÉSUMÉ
Critical interactions between the nervous system and the immune system during experimental autoimmune myasthenia gravis (EAMG) were examined in an animal model for human MG after immunization of adult female Lewis rats with Torpedo acetylcholine receptor (AChR) and complete Freund's adjuvant. Immunized rats depicted marked clinical severity of the disease. Using enzyme-linked immunospot (ELISPOT) assay and in situ hybridization techniques, immune responses in these animals were examined and showed elevated numbers of anti-AChR IgG secreting B cells and AChR reactive interferon (IFN)-gamma-secreting cells, enhanced mRNA expression of the proinflammatory cytokines IFN-gamma and tumour necrosis factor (TNF)-alpha as Th1 subset and the anti-inflammatory cytokines interleukin (IL)-4 and IL-10 as a Th2 subset, and transforming growth factor (TGF)-beta as a Th3 cytokine. Corticosterone and prostaglandin E(2) (PGE(2)) levels were measured by radioimmunoassay and illustrated increased production after immunization. Surgical denervation of the spleen reduced significantly the clinical severity of the disease, suppressed the numbers of IgG and IFN-gamma-secreting cells, down-regulated the mRNA expression for cytokines and reduced corticosterone and PGE(2) production. As controls, sham-operated rats were used and showed results as the EAMG non-denervated control rats. The data present herein, and for the first time, substantial effects of the nervous system on immune responses that may influence the outcome of EAMG. These effects were not dependent on cytokine inhibitory mediators such as prostaglandins or stress hormones. IL-10 and TGF-beta, the two potent immunosuppressive cytokines, were also suppressed, indicating a general suppression by splenic denervation. More investigations are initiated at our laboratories to understand the evident neural control over the immune system during challenges leading to the break of tolerance and development of autoimmunity, which may assist in innovative therapeutic approaches.
Sujet(s)
Dénervation/méthodes , Myasthénie auto-immune expérimentale/chirurgie , Rate/chirurgie , Animaux , Lymphocytes B/immunologie , Corticostérone/sang , Dinoprostone/immunologie , Femelle , Immunoglobuline G/immunologie , Interféron gamma/immunologie , Interleukine-4/immunologie , Myasthénie auto-immune expérimentale/immunologie , ARN messager/analyse , Rats , Rats de lignée LEW , Récepteurs cholinergiques/immunologie , Rate/innervation , Lymphocytes T/immunologie , Facteur de croissance transformant bêta/immunologie , Facteur de nécrose tumorale alpha/immunologieRÉSUMÉ
The aim of the present study was to investigate the effects of IL-1beta and Escherichia coli on the expression and secretion of MIP-2, the mouse equivalent to human IL-8, MCP-1 and RANTES in the kidneys of mice with acute pyelonephritis. Female Bki NMRI, as well as IL-1beta deficient mice and their wild-type littermates, were transurethrally infected with either E. coli CFT 073 or injected with NaCl 0.9% (w/v) and thereafter obstructed for 6 h. The Bki NMRI mice were killed at 0, 24, 48 h and 6 days and the IL-1beta-deficient mice at 48 h. Chemokine mRNA and protein levels peaked at 24 h for the tested chemokines with the mRNA expression localized in the tubular epithelial cells and for MIP-2 also in neutrophils. Obstruction per se, also induced a chemokine expression similar to E. coli infection although at a lower level. Interestingly, MIP-2 levels were higher in the IL-1beta deficient mice as compared with the wild-type littermates. Likewise, the inflammatory changes were more frequent and, when present, more widespread in the IL-1beta-deficient mice than in the wild-type mice. Stimulation of a human renal tubular epithelial cell line (HREC), A498 and of primary human mesangial cells (HMC) with the same bacterial antigen depicted gene expression of the same chemokines. A rapid release of IL-8 and MCP-1 was observed from both cell types. RANTES response was delayed both in the HREC and the HMC. We conclude that acute E. coli pyelonephritis induces a MIP-2/IL-8, MCP-1 and RANTES expression and secretion localized primarily to the epithelial cells and that this production is confirmed after in vitro stimulation with the same bacterial antigen of human epithelial and mesangial cells. Blockade of induction of chemokine response may thus be an attractive target for possible therapeutic intervention.
Sujet(s)
Infections à Escherichia coli/immunologie , Interleukine-1/immunologie , Pyélonéphrite/immunologie , Maladie aigüe , Animaux , Chimiokine CCL2/métabolisme , Chimiokine CCL5/métabolisme , Chimiokine CXCL2 , Chimiokines/biosynthèse , Chimiokines/génétique , Cellules épithéliales/immunologie , Infections à Escherichia coli/anatomopathologie , Femelle , Expression des gènes , Humains , Tubules rénaux/métabolisme , Souris , Lignées consanguines de souris , Monokines/métabolisme , Pyélonéphrite/microbiologie , Pyélonéphrite/anatomopathologie , ARN messager/génétique , Régulation positiveRÉSUMÉ
Chemokines are small-secreted proteins that stimulate the directional migration of leukocytes and thereby mediate the inflammatory process. The present study investigates the capacity of human gingival fibroblasts to produce the beta chemokine Rantes/CCL5. In situ hybridization, immunohistochemistry and ELISA were used to measure the induction of Rantes/CCL5 at the mRNA and protein levels, both in unstimulated gingival fibroblasts as well as in fibroblasts treated with the proinflammatory cytokines tumor necrosis factor (TNF)alpha or interleukin (IL)-1beta. TNFalpha in different concentrations (0.1-10 ng/ml) induced Rantes/CCL5 mRNA expression and protein production in 24-h cultures of human gingival fibroblasts. The expression of Rantes/CCL5-mRNA and protein production, induced by TNFalpha, was evident at 6 h and thereafter increased continuously during the study period (24 h). IL-1beta (3-300 pg/ml) also enhanced the production of Rantes/CCL5 in gingival fibroblasts. The amount of Rantes/CCL5 induced by IL-1beta (300 pg/ml), however, was less than that induced by TNFalpha (10 ng/ml). The study suggests that human gingival fibroblasts, by producing the chemokine Rantes/CCL5, participate in the regulation of the host response during the inflammatory process in the periodontal tissue.
Sujet(s)
Chimiokine CCL5/biosynthèse , Gencive/métabolisme , Cellules cultivées , Enfant , Fibroblastes/effets des médicaments et des substances chimiques , Fibroblastes/métabolisme , Gencive/cytologie , Gencive/effets des médicaments et des substances chimiques , Humains , Techniques immunoenzymatiques , Hybridation in situ , Interleukine-1/pharmacologie , ARN messager/analyse , Protéines recombinantes/pharmacologie , Facteur de nécrose tumorale alpha/pharmacologieRÉSUMÉ
The most effective protection against human leishmaniasis has been achieved following vaccination with live promastigotes. Killed promastigotes + BCG can protect, albeit to a lower degree. To explore what mechanisms may be involved in these differences, the ability of live and dead promastigotes to induce immune responses were evaluated in vitro. The data showed that live and dead promastigotes differ in their ability to induce proliferation and cytokine production. Cytokine gene expression of Th1 related cytokines (IL-12, IFNgamma and TNFalpha) in adult PBMC was more evident to live than to heat killed promastigotes. This was coupled with significantly higher number of IFNgamma secreting cells induced by live than killed promastigotes. However, alpha-IL-12 antibodies did not block the IFNgamma response induced by live promastigotes. Proliferative responses were variable. In contrast to adult PBMC no IFNgamma secreting MNC could be detected in cord blood. However, in these cells the live promastigotes consistently induced higher proliferative response compared to dead. Implications of these findings are discussed.
Sujet(s)
Cytokines/biosynthèse , Leishmania/immunologie , Vaccins antiprotozoaires/immunologie , Adulte , Animaux , Antigènes de protozoaire/immunologie , Division cellulaire/effets des médicaments et des substances chimiques , Cytokines/génétique , Sang foetal/cytologie , Régulation de l'expression des gènes , Humains , Nouveau-né , Interféron gamma/biosynthèse , Interféron gamma/génétique , Interleukine-12/biosynthèse , Interleukine-12/génétique , Interleukine-12/immunologie , Leishmania/croissance et développement , Activation des lymphocytes , ARN messager/biosynthèse , Reproductibilité des résultats , Lymphocytes auxiliaires Th1/immunologie , Lymphocytes auxiliaires Th1/métabolisme , Facteur de nécrose tumorale alpha/biosynthèse , Facteur de nécrose tumorale alpha/génétique , Vaccination , Vaccins inactivés/immunologieRÉSUMÉ
Interleukin-1beta (IL-1beta), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) are proinflammatory cytokines that are thought to play a role in bone remodeling, bone resorption, and new bone deposition. In the present work, in situ hybridization was performed to measure the messenger RNA expression of IL-1beta, IL-6, and TNF-alpha at 3, 7, and 10 days after the application of orthodontic force on the maxillary first molars of 12 rats. The contralateral side and 3 untreated rats served as controls. Measurements of the messenger RNA expression were selected as the means to investigate the role of orthodontic force in de novo synthesis of proinflammatory cytokines. After the application of force, the induction of IL-1beta and IL-6 was observed to reach a maximum on day 3 and to decline thereafter. No messenger RNA induction of either cytokine was measured in the control teeth. The messenger RNA expression of TNF-alpha was not detected at any time point of this study in the experimental or contralateral sides or in the control animals. Our data support the hypothesis that these proinflammatory cytokines may play important roles in bone resorption after the application of orthodontic force.
Sujet(s)
Cytokines/biosynthèse , Médiateurs de l'inflammation/métabolisme , Desmodonte/métabolisme , Mouvement dentaire , Animaux , Moelle osseuse/métabolisme , Moelle osseuse/anatomopathologie , Remodelage osseux/physiologie , Résorption osseuse/métabolisme , Résorption osseuse/anatomopathologie , Régulation de l'expression des gènes , Traitement d'image par ordinateur , Hybridation in situ , Interleukine-1/biosynthèse , Interleukine-6/biosynthèse , Mâle , Maxillaire/métabolisme , Maxillaire/anatomopathologie , Molaire/physiologie , Ostéogenèse/physiologie , Desmodonte/anatomopathologie , Pression , ARN messager/génétique , Rats , Rat Wistar , Statistiques comme sujet , Contrainte mécanique , Facteur de nécrose tumorale alpha/biosynthèseRÉSUMÉ
We have examined the role of alpha and beta chemokines in the promotion of the ontogenetic development of the brain. RANTES was expressed preferentially in human fetal astrocytes in an age-dependent manner. Astrocytes from 5-week-old brains showed high proliferation and reduced survival, whereas 10-week-old astrocytes exhibited opposite effects. These effects were suppressed by anti-RANTES or anti-RANTES receptor antibodies and were enhanced by recombinant RANTES. RANTES induced tyrosine phosphorylation of several cellular proteins and nuclear translocation of STAT-1 in astrocytes. Interferon-gamma (IFN-gamma) was required for RANTES effects because RANTES induced IFN-gamma and only 10-week-old astrocytes expressed the IFN-gamma receptor. Blocking of IFN-gamma with antibody reversed the effects of RANTES, indicating that cytokine/chemokine networks are critically involved in brain development.
Sujet(s)
Astrocytes/physiologie , Chimiokine CCL5/métabolisme , Interféron gamma/métabolisme , Interleukine-8/métabolisme , Prosencéphale/embryologie , Animaux , Astrocytes/cytologie , Cycle cellulaire/physiologie , Survie cellulaire , Cellules cultivées , Chimiokine CCL5/génétique , Protéines de liaison à l'ADN/métabolisme , Embryon de mammifère/cytologie , Femelle , Humains , Immunotransfert , Immunohistochimie , Hybridation in situ , Interleukine-8/génétique , Souris , Souris de lignée C57BL , Phosphorylation , Grossesse , Premier trimestre de grossesse , Prosencéphale/cytologie , Prosencéphale/métabolisme , ARN messager/métabolisme , Récepteurs CCR5/métabolisme , Protéines recombinantes/génétique , Protéines recombinantes/métabolisme , Facteur de transcription STAT-1 , Transactivateurs/métabolismeRÉSUMÉ
The aim of this study was to investigate the influence of IL-6 on mortality, bacterial growth and cytokine expression in experimental acute pyelonephritis. Female IL-6-deficient mice and their wild-type counterparts, 8-10 weeks old, were infected with Escherichia coli CFT 073 or injected with NaCl 0.9% (w/v) via the urethra and thereafter obstructed for 6 h. Animals were killed at 48 h, 6 days or 8 weeks and cytokine and bacterial renal levels were assessed at each time point. We found that IL-6-deficient mice had increased mortality and extensive renal bacterial growth on day 6, compared with wild-type mice (P < 0.05) and the histopathological changes were generally more severe and widespread in the IL-6-deficient mice. Peak mRNA expression of IL-1beta, IL-4, IL-10, IL-12 and interferon-gamma (IFN-gamma) occurred 48 h after infection in both IL-6 knock out and wild-type mice. Transforming growth factor-beta (TGF-beta) levels also peaked at 48 h in E. coli-infected wild-type mice, while in the IL-6-deficient strain both TGF-beta mRNA and protein levels were significantly lower at 48 h than wild-type levels (P < 0.0008 and P < 0.03, respectively) and remained stationary throughout the study period. Animals injected with NaCl 0.9% (w/v) displayed a similar decrease in TGF-beta expression (P < 0.02). When splenocytes from the IL-6-deficient mice were incubated with murine recombinant IL-6, TGF-beta levels increased to those of wild-type mice. No increase was observed when splenocytes from wild-type mice were incubated with the same doses of rIL-6. We therefore conclude that IL-6 plays an important role in bacterial clearance and directly influences the TGF-beta levels in experimental acute pyelonephritis. We also demonstrate that urethral obstruction per se induces an increase in TGF-beta the magnitude of which is decreased in IL-6-deficient mice.
Sujet(s)
Cytokines/biosynthèse , Cytokines/génétique , Infections à Escherichia coli/immunologie , Interleukine-6/déficit , Rein/immunologie , Pyélonéphrite/immunologie , Animaux , Escherichia coli/croissance et développement , Infections à Escherichia coli/microbiologie , Infections à Escherichia coli/anatomopathologie , Femelle , Interleukine-6/génétique , Rein/microbiologie , Rein/anatomopathologie , Souris , Souris knockout , Pyélonéphrite/microbiologie , Pyélonéphrite/anatomopathologie , ARN messager/génétique , ARN messager/métabolisme , Facteur de croissance transformant bêta/biosynthèse , Facteur de croissance transformant bêta/génétiqueRÉSUMÉ
BACKGROUND AND OBJECTIVE: Nickel sulphate stimulates the proliferation of lymphocytes in nickel-allergic subjects. However, nickel-induced stimulation of lymphocytes from control persons without clinical symptoms of nickel allergy has also been reported. The aim of the present study was to correlate T cell activity, measured by DNA synthesis and the expression of Th1 [interleukin (IL)-2, tumour necrosis factor (TNF)-beta and interferon (IFN)-gamma] and Th2 (IL-4) cytokines, in short-term (up to 72 h) culture of nickel-stimulated peripheral blood mononuclear cells (PBMC) from nickel-allergic patients compared to control subjects. METHODS: DNA synthesis was measured by the incorporation of [methyl-(3)H]thymidine. The production of IL-2, TNF-beta, IFN-gamma and IL-4 was measured in the supernatants of the cultures by ELISA. In situ hybridization for mRNA was performed using oligonucleotide probes for IL-4, IFN-gamma and TNF-beta in cell smears. RESULTS: Already after 24 h and proceeding through the remaining culture period, there was a statistically significant (p<0.001) difference in the concentrations of IL-2 between patients and controls. There was a significant (p<0.01) difference in DNA synthesis (stimulation index) between the patients and control subjects at 72 h, and also at the same time a difference in the concentrations of TNF-beta (p<0.05) and IL-4 (p<0.01). In the in situ hybridization study, TNF-beta was found to be the only one of the studied cytokines that differed between the nickel-allergic and control subjects, this difference being most evident at 72 h (p<0.01). CONCLUSIONS: Our results indicate a difference between nickel-allergic and non-allergic subjects in the synthesis of DNA and production of cytokines when PBMC are stimulated by nickel sulphate, and IL-2 may be regarded as a critical and early-occurring cytokine.
Sujet(s)
Cytokines/biosynthèse , ADN/biosynthèse , Eczéma de contact allergique/immunologie , Agranulocytes/effets des médicaments et des substances chimiques , Nickel/effets indésirables , Adulte , Sujet âgé , Cellules cultivées , Cytokines/analyse , Eczéma de contact allergique/étiologie , Femelle , Humains , Interleukine-2/analyse , Interleukine-4/analyse , Agranulocytes/immunologie , Lymphotoxine alpha/analyse , Adulte d'âge moyen , Facteurs tempsRÉSUMÉ
BACKGROUND, AIMS: The effect of triclosan (2,4,4'-trichloro-2'-hydroxyl-diphenyl ether) on the production of interferon-gamma (IFN-gamma) and the expression of major histocompatibility complex (MHC) class II antigen was studied in human gingival fibroblasts isolated from 4 individuals. METHODS/RESULTS: All cell lines demonstrated high IFN-gamma production in 24-h cultures of human gingival fibroblasts stimulated by phytohemagglutinin (PHA) (5 microg/ml). Human gingival fibroblasts showed a high expression of MHC class II when stimulated with 500 and 1,000 pg/ml rIFN-gamma in 7-day cultures. Treatment of the cells with triclosan (0.5 microg/ml) reduced both IFN-gamma production and MHC class II expression in human gingival fibroblast cultures. Similar inhibitory effects on IFN-gamma production and MHC class II expression were observed when the anti-inflammatory agent dexamethazone (1 microM) was used. CONCLUSION: The present study further supports the view that the agent has an anti-inflammatory effect in addition to its antibacterial capacity.
Sujet(s)
Anti-infectieux locaux/pharmacologie , Gencive/effets des médicaments et des substances chimiques , Gencive/métabolisme , Antigènes d'histocompatibilité de classe II/biosynthèse , Interféron gamma/biosynthèse , Triclosan/pharmacologie , Cellules cultivées , Enfant , Test ELISA , Fibroblastes/effets des médicaments et des substances chimiques , Fibroblastes/métabolisme , Gencive/cytologie , Humains , Phytohémagglutinine/pharmacologieRÉSUMÉ
OBJECTIVE: To examine critical interactions between the nervous system and the immune system during experimental African trypanosomiasis. METHODS AND RESULTS: Inoculation of Trypanosoma brucei brucei resulted in early interferon (IFN)-gamma production, elevated corticosterone and prostaglandin E(2) (PGE(2)) levels and increased splenocyte proliferation, as measured by enzyme-linked immunospot assay, radioimmunoassay and thymidine incorporation assay, respectively. Splenic denervation suppressed IFN-gamma, corticosterone and PGE(2) production, enhanced splenocyte proliferation, and significantly reduced parasitemia and prolonged rat survival. CONCLUSIONS: Our data show substantial effects of the nervous system on early immune responses that may influence the outcome of this disease. These effects were not dependent on cytokine inhibitory mediators such as prostaglandins or stress hormones. More investigations are required to understand the evident neural control over the immune system during infectious challenges, which may assist in novel therapeutic approaches.
Sujet(s)
Rate , Trypanosoma brucei brucei , Maladie du sommeil/immunologie , Animaux , Plexus coeliaque/enzymologie , Plexus coeliaque/immunologie , Plexus coeliaque/chirurgie , Division cellulaire/immunologie , Corticostérone/sang , Corticostérone/immunologie , Dénervation , Dinoprostone/sang , Dinoprostone/immunologie , Interféron gamma/sang , Interféron gamma/immunologie , Mâle , Neuro-immunomodulation/immunologie , Rats , Rat Sprague-Dawley , Rate/cytologie , Rate/innervation , Rate/parasitologie , Analyse de survie , Maladie du sommeil/mortalité , Tyrosine 3-monooxygenase/analyseRÉSUMÉ
PURPOSE: To study the effect of an angiotensin II type 1 receptor antagonist, losartan, on cytokine expression, kidney growth and renal scarring in experimental acute pyelonephritis. MATERIALS AND METHODS: Female Bki NMRI mice, 8 weeks old were infected with E. coli CFT 073 via the urethra. Mice were divided into four groups; either left untreated; or treated with NaCl 0.9%; or an angiotensin II type 1 receptor antagonist, losartan, in doses of 1 mg. or 40 mg. /kg. body weight. The treatment was given daily i.p. for 48 hours, 3 weeks or 8 weeks respectively. Kidneys were weighed and sectioned for histo-pathology and in situ hybridization for mRNA of IL-1beta, TNF-alpha, IL-4, IL-6, IL-10, IL-12, TGF-beta and IFN-gamma. Homogenized kidneys were used for EIA of TGF-beta and bacterial growth. RESULTS: The mRNA expression of the studied cytokines generally peaked at 48 hours in all four groups. In animals treated with losartan, kidney TGF-beta, IFN-gamma and IL-6 decreased significantly at 3 and 8 weeks as compared with controls, untreated or those treated with NaCl, (p <0.005 respectively). Infection was associated with a declining kidney weight, also in the presence of losartan. A 50% reduction of the spread of renal scarring was observed in the losartan treated group, but this did however not reach significance. The proportion of kidneys showing bacterial growth was not influenced by losartan although in these kidneys the mean bacterial counts at 3 weeks were significantly higher in the losartan treated mice (p <0.006). CONCLUSIONS: Losartan is associated with downregulation of TGF-beta, IFN-gamma and IL-6 and may, in combination with antimicrobial therapy, reduce the risk of cortical renal scarring in recurrent acute pyelonephritis in infants.
Sujet(s)
Antagonistes des récepteurs aux angiotensines , Régulation négative/effets des médicaments et des substances chimiques , Losartan/pharmacologie , Pyélonéphrite/métabolisme , Facteur de croissance transformant bêta/biosynthèse , Facteur de croissance transformant bêta/effets des médicaments et des substances chimiques , Maladie aigüe , Animaux , Femelle , Souris , Lignées consanguines de souris , ARN messager/analyse , Facteur de croissance transformant bêta/génétiqueRÉSUMÉ
Interferon gamma (IFN-gamma) is a potential immunoregulatory cytokine, which is secreted mainly by cells of immune origin. In this study, we examined the capacity of human gingival fibroblasts as non-professional immune cells to express IFN-gamma messenger RNA (mRNA) and to produce the protein. Cultures of fibroblast cells were established from gingival biopsies from three children. The expression of mRNA for IFN-gamma was studied by in situ hybridization, and the level of IFN-gamma was determined by cell-released capturing ELISA. Treatment of the cells with phytohaemagglutinin (PHA) (2.5, 5.0, and 10 microg/ml) increased the number of IFN-gamma mRNA expressing cells and the protein production at 1, 6, and 24 h. Non-stimulated cells did not reveal measurable levels of IFN-gamma mRNA or the protein. The inflammatory cytokines interleukin 1beta (IL-1beta) (100 microg/ml) and tumour necrosis factor alpha (TNFalpha) (10 ng/ml) did not affect IFN-gamma mRNA expression or protein production. Treatment of the cells with 1 microM phorbol 12-myristate-13-acetate (PMA) stimulated IFN-gamma mRNA expression but had no effect on IFN-gamma protein production. We conclude that human gingival fibroblasts not only transcribe IFN-gamma mRNA but also produce the IFN-gamma protein in response to PHA. The finding that human gingival fibroblasts, produce the cytokine IFN-gamma, further support the concept that these cells take an active part in the modulation of the inflammatory and immune response in the periodontal tissue.
Sujet(s)
Fibroblastes/immunologie , Gencive/immunologie , Interféron gamma/biosynthèse , Phytohémagglutinine/immunologie , Enfant , Fibroblastes/cytologie , Fibroblastes/effets des médicaments et des substances chimiques , Gencive/cytologie , Gencive/effets des médicaments et des substances chimiques , Humains , Interféron gamma/génétique , Parodontite/anatomopathologie , Phytohémagglutinine/pharmacologie , ARN messager , Facteurs tempsRÉSUMÉ
Bidirectional signalling between Trypanosoma brucei brucei and CD8+ T cells involves reciprocal action of the parasite-derived trypanosome derived lymphocyte triggering factor (TLTF) and lymphocyte-derived IFN-gamma. Herein we further characterize this relationship and report quantitation of TLTF secretion into culture supernatants using a newly developed ELISA. Secretion is induced by IFN-gamma in a dose-response manner, with 100 U/ml giving maximal yields of bioactive TLTF as assessed by ELISA and ELISPOT. This is a constitutive and active secretion. Furthermore, IFN-gamma-induced secretion was dependent on tyrosine protein kinase activity. Specific blockers of this signalling system resulted in lower yields of TLTF in the culture supernatants.
Sujet(s)
Interféron gamma/pharmacologie , Protein-tyrosine kinases/physiologie , Protéines de protozoaire/métabolisme , Trypanosoma brucei brucei/physiologie , Maladie du sommeil/parasitologie , Animaux , Anticorps monoclonaux , Technique de Western , Relation dose-effet des médicaments , Électrophorèse sur gel de polyacrylamide , Antienzymes/composition chimique , Test ELISA , Technique d'immunofluorescence , Interféron gamma/physiologie , Agranulocytes/immunologie , Rats , Rats de lignée LEW , Rat Sprague-Dawley , Transduction du signal , Trypanosoma brucei brucei/immunologie , Tyrphostines/composition chimiqueRÉSUMÉ
African trypanosomiasis is characterized by progressive central nervous system (CNS) involvement. Using single and double immunohistochemistry, we evaluated the induction of alpha- and beta-chemokines in brains of Sprague-Dawley rats infected with Trypanosoma brucei brucei (T. b. brucei) and identified their cellular source. The results showed high production of MIP-2, RANTES and MIP-1alpha and to a lower extend MCP-1 in infected animals compared to controls. MIP-2, RANTES and MIP-1alpha were produced early by astrocytes and microglia and later by macrophages and T-cells. These findings suggest that chemokines may contribute to the immunopathogenesis that occurs in the CNS early during infections.
Sujet(s)
Encéphale/métabolisme , Chimiokines/biosynthèse , Maladie du sommeil/métabolisme , Animaux , Astrocytes/métabolisme , Astrocytes/anatomopathologie , Encéphale/immunologie , Encéphale/parasitologie , Encéphale/anatomopathologie , Chimiokine CCL2/biosynthèse , Chimiokine CCL3 , Chimiokine CCL4 , Chimiokine CCL5/biosynthèse , Chimiokine CXCL2 , Immunohistochimie , Protéines inflammatoires des macrophages/biosynthèse , Macrophages/métabolisme , Macrophages/anatomopathologie , Mâle , Microglie/métabolisme , Microglie/anatomopathologie , Monokines/biosynthèse , Rats , Rat Sprague-Dawley , Lymphocytes T/métabolisme , Lymphocytes T/anatomopathologie , Facteurs temps , Trypanosoma brucei brucei/pathogénicité , Maladie du sommeil/immunologie , Maladie du sommeil/anatomopathologieRÉSUMÉ
The expression of Interleukin-6 (IL-6) was studied in normal dorsal root ganglia (DRG) of juvenile and foetal humans, using immunohistochemistry and in situ hybridization techniques. There was an expression of IL-6-like immunoreactivity in more than 75% out of neuronal cells in the juvenile ganglia with a peripheral localization, and also an expression in the foetal ganglion cells. There was a co-localization of IL-6 with substance P (SP) and calcitonin gene-related peptide (CGRP) in more than 60% of the DRG cells, respectively. By in situ hybridization 0.9% of the cells in the juvenile ganglia and 1.1% of the cells in the foetal ganglia showed a positive signal for IL-6. In addition, expression of IL-6 was found in juvenile medulla spinalis, preferentially in the white matter.
Sujet(s)
Ganglions sensitifs des nerfs spinaux/métabolisme , Interleukine-6/analyse , Peptide relié au gène de la calcitonine/analyse , Enfant , Ganglions sensitifs des nerfs spinaux/cytologie , Ganglions sensitifs des nerfs spinaux/embryologie , Régulation de l'expression des gènes au cours du développement , Humains , Immunohistochimie , Hybridation in situ , Interleukine-6/génétique , Mâle , ARN messager/génétique , ARN messager/métabolisme , Substance P/analyseRÉSUMÉ
Cytokines are important signaling proteins that are liberated during immune challenges and exhibit many modulatory activities. However, their role in periodontal modeling during orthodontic tooth movement is not fully understood. The aim of this study was to analyze effects of mechanical force during orthodontic tooth movement, in the pressure zone, on the induction of interferon-gamma (IFN-gamma) as a proinflammatory cytokine of Th1 type and interleukin-4 (IL-4)/IL-10 as anti-inflammatory cytokines of Th2 type. In 12 Wistar rats 40-45 days old, the maxillary first molar was moved mesially by means of a closed coil spring for 3, 7, and 10 days. The contralateral side served as a control. IFN-gamma, IL-4, and IL-10 mRNA were determined by in situ, hybridization, and protein levels of IFN-gamma was measured by immunohistochemistry. Induction of IFN-gamma at both mRNA and protein levels was significantly higher on the experimental side than on the contralateral control side on day 3. The signal gradually became stronger on day 7 and remained high on day 10. Cytokines of the Th2 type (IL-4 and IL-10) were not detected at all examined time points in both pressure and contralateral control sides. Considering the potential immunoregulatory roles played by IFN-gamma, our data suggest that IFN-gamma may be involved in periodontium remodeling during orthodontic tooth movement.